2022 Revenues ($USD) : $1,426,188,000
2022 R&D spend : n/a
2022 Number of Employees : 5,000
Fiscal Year End : 12/31/2021
Company CEO : Matthew Trerotola, CEO

DJO parent company Enovis (formerly Colfax) completed the spinoff of its fabrication technology business in April. The result is that Enovis is now a major, stand-alone orthopedic device company — No. 56 in the 2022 Big 100 rankings of the largest medical device companies. Since it went stand-alone, Enovis has been engaging in tuck-in acquisitions. For example, in May, it acquired the assets of Outcome-Based Technologies‘ hip and knee bracing portfolio, adding the Excyabir hip brace and CryoKnee knee braces to its DonJoy bracing brand. In July, Enovis also completed the acquisition of Insight Medical and its FDA-cleared Arvis augmented reality platform for hip and knee replacement surgery. –CN